Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLRCNYSE:FVRNASDAQ:INVNASDAQ:KVAC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLRCClimateRock$12.05+0.3%$12.04$11.53▼$12.15$54.83M-0.0117,783 shs1,029 shsFVRFrontView REIT$11.76-5.8%$11.76$10.61▼$19.76$238.19MN/A259,778 shs380,375 shsINVInnventure$4.85-1.6%$5.02$3.00▼$18.75$263.42M0.18171,039 shs22,259 shsKVACKeen Vision Acquisition$11.42+0.3%$11.32$10.61▼$11.42$220.58M-0.0455,491 shs2,117 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLRCClimateRock0.00%0.00%0.00%+0.17%+4.47%FVRFrontView REIT0.00%+1.25%+7.83%+12.11%+1,247,999,900.00%INVInnventure0.00%+8.35%-17.42%+12.81%+492,999,900.00%KVACKeen Vision Acquisition0.00%+0.18%0.00%+1.15%+7.45%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLRCClimateRockN/AN/AN/AN/AN/AN/AN/AN/AFVRFrontView REIT1.7805 of 5 stars3.20.02.50.00.60.00.6INVInnventure2.133 of 5 stars3.80.00.00.00.02.50.6KVACKeen Vision AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLRCClimateRock 0.00N/AN/AN/AFVRFrontView REIT 2.40Hold$16.8042.86% UpsideINVInnventure 3.50Strong Buy$14.00188.66% UpsideKVACKeen Vision Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CLRC, KVAC, INV, and FVR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/17/2025FVRFrontView REITBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underperform$15.00 ➝ $11.006/17/2025FVRFrontView REITJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$14.00 ➝ $12.006/10/2025FVRFrontView REITJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$15.00 ➝ $14.005/6/2025FVRFrontView REITBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$15.004/11/2025FVRFrontView REITWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$19.00 ➝ $17.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLRCClimateRockN/AN/A$0.24 per share51.24($2.67) per shareN/AFVRFrontView REIT$66.68M3.37$0.47 per share24.78$30.23 per share0.39INVInnventure$1.22M212.64N/AN/A$17.18 per share0.28KVACKeen Vision AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLRCClimateRock$480KN/A0.00∞N/AN/AN/A-1.77%N/AFVRFrontView REIT-$22.21MN/A0.009.88N/AN/AN/AN/A8/13/2025 (Estimated)INVInnventure-$78.19MN/A0.00N/AN/AN/A-21.70%-15.11%8/18/2025 (Estimated)KVACKeen Vision AcquisitionN/AN/A0.00∞N/AN/AN/AN/A7/23/2025 (Estimated)Latest CLRC, KVAC, INV, and FVR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025INVInnventure-$0.13$0.60+$0.73-$3.10$0.58 million$0.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLRCClimateRockN/AN/AN/AN/AN/AFVRFrontView REIT$0.867.31%N/AN/AN/AINVInnventureN/AN/AN/AN/AN/AKVACKeen Vision AcquisitionN/AN/AN/AN/AN/ALatest CLRC, KVAC, INV, and FVR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/15/2025FVRFrontView REITquarterly$0.21507.4%6/30/20256/30/20257/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLRCClimateRockN/AN/AN/AFVRFrontView REIT0.600.170.17INVInnventure0.020.220.11KVACKeen Vision AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLRCClimateRock55.48%FVRFrontView REITN/AINVInnventure55.98%KVACKeen Vision Acquisition51.72%Insider OwnershipCompanyInsider OwnershipCLRCClimateRock42.21%FVRFrontView REIT4.30%INVInnventure23.13%KVACKeen Vision Acquisition22.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLRCClimateRock24.55 million2.63 millionNot OptionableFVRFrontView REITN/A19.09 million18.27 millionN/AINVInnventureN/A53.49 million41.12 millionN/AKVACKeen Vision AcquisitionN/A19.37 million14.95 millionNot OptionableCLRC, KVAC, INV, and FVR HeadlinesRecent News About These CompaniesKVAC Keen Vision Acquisition Corporation - Seeking AlphaJune 29, 2025 | seekingalpha.comKeen Vision Issues Promissory Note to Extend DeadlineJune 27, 2025 | tipranks.comKeen Vision Acquisition Corporation (KVACW) - Yahoo FinanceJune 27, 2025 | au.finance.yahoo.comKeen Vision Acquisition (NASDAQ:KVAC) Stock Price Up 0.5% - Here's What HappenedJune 25, 2025 | marketbeat.comMedera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025June 13, 2025 | globenewswire.comKeen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Up 283.3% in MayJune 12, 2025 | marketbeat.comKeen Vision Acquisition Corporation Ordinary SharesJune 6, 2025 | fxempire.comFMedera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 CongressMay 12, 2025 | globenewswire.comMedera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF SummitApril 1, 2025 | globenewswire.comKeen Vision Acquisition Corp. Secures Funding to Extend Merger DeadlineMarch 30, 2025 | investing.comMedera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection FractionMarch 20, 2025 | globenewswire.comMedera Completes Patient Dosing for Heart Failure TreatmentMarch 11, 2025 | finance.yahoo.comMedera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection FractionMarch 11, 2025 | globenewswire.comKeen Vision Acquisition Corp. extends business combination periodMarch 1, 2025 | uk.investing.comMedera's Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, UtrechtFebruary 10, 2025 | globenewswire.comMedera, Inc. to Participate in Two Upcoming Investor ConferencesFebruary 7, 2025 | globenewswire.comKeen Vision Acquisition Corp. extends Business combination deadlineJanuary 24, 2025 | msn.comKVAC stock soars to all-time high of $11.03 amid market optimismJanuary 22, 2025 | msn.com(KVAC) Long Term Investment AnalysisJanuary 22, 2025 | news.stocktradersdaily.comNWhen the Price of (KVAC) Talks, People ListenNovember 29, 2024 | news.stocktradersdaily.comNKeen Vision Acquisition Corp Share Price (KVAC.US)November 6, 2024 | lse.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 AI Infrastructure Stocks With Strong Growth, Not HypeBy Chris Markoch | June 26, 2025View 3 AI Infrastructure Stocks With Strong Growth, Not HypeAddition by Subtraction: Intel’s New Strategy Energizes InvestorsBy Jeffrey Neal Johnson | June 27, 2025View Addition by Subtraction: Intel’s New Strategy Energizes InvestorsSoundHound’s AI Growth Story Is Just Getting StartedBy Gabriel Osorio-Mazilli | June 16, 2025View SoundHound’s AI Growth Story Is Just Getting Started3 Stocks With Near-Unanimous Buys That Could Rally HigherBy Nathan Reiff | July 2, 2025View 3 Stocks With Near-Unanimous Buys That Could Rally HigherCLRC, KVAC, INV, and FVR Company DescriptionsClimateRock NASDAQ:CLRC$12.04 +0.04 (+0.29%) As of 04/9/2025 This is a fair market value price provided by Polygon.io. Learn more.ClimateRock focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue an initial business combination within climate change, environment, renewable energy and emerging, and clean technologies. The company was incorporated in 2021 and is based in London, the United Kingdom.FrontView REIT NYSE:FVR$11.76 -0.72 (-5.77%) As of 03:58 PM EasternFrontView REIT specializes in real estate investing.Innventure NASDAQ:INV$4.85 -0.08 (-1.62%) As of 04:00 PM EasternInnventure Inc. founds, funds and operates companies with a focus on transformative, sustainable technology solutions acquired or licensed from multinational corporations. Innventure Inc., formerly known as Learn CW Investment Corporation, is based in ORLANDO, Fla.Keen Vision Acquisition NASDAQ:KVAC$11.42 +0.03 (+0.25%) As of 02:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Keen Vision Acquisition Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combination with one or more businesses or entities. It also intends to focus on businesses in the biotechnology, consumer goods, and agriculture sectors. The company was incorporated in 2021 and is based in Summit, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
